Article

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinoma

2025-04-10

Abstract excerpt

<title>Abstract</title> <p><bold>Introduction: </bold>Early-stage poorly differentiated lung adenocarcinoma (LUAD) is plagued by a high risk of postoperative recurrence, and its prognostic heterogeneity complicates treatment and surveillance planning. We conducted this integrative multi-omics study to identify those patients with a truly high risk of adverse outcomes. <bold>Methods: </bold>Whole-exome, RNA and wh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b516a193-efd3-59c1-9e94-b112f58ec4d1
DOI: 10.21203/rs.3.rs-6082622/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaDOI 10.21203/rs.3.rs-6082622/v1Read

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaSemantic proximity Read

Multi-omics characterization and machine learning of lung adenocarcinoma molecular subtypes to guide precise chemotherapy and immunotherapy.Semantic proximity Read

Molecular charcterization of lung adenocarcinoma combining whole exome sequencing, copy number analysis and gene expression profilingSemantic proximity Read

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung AdenocarcinomaSemantic proximity Read

Integration of multi-omics profiling reveals an epigenetic-based molecular classification of lung adenocarcinoma: implications for drug sensitivity and immunotherapy response predictionSemantic proximity Read

Integrated Multi-Omics Analysis of Lung Adenocarcinoma (TCGA-LUAD): A Comprehensive Study of Genomic, Epigenomic, Copy Number Variations, and Transcriptomic AlterationsSemantic proximity Read

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancerSemantic proximity Read

Proteogenomic Characterization of High-Grade Lung Neuroendocrine Carcinoma Deciphers Molecular Diversity and Potential Biomarkers of Different Histological Subtypes in Chinese PopulationSemantic proximity Read

Integrated multi-omics analysis and machine learning to refine molecular subtypes, prognosis, and immunotherapy in lung adenocarcinomaSemantic proximity Read

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUADSemantic proximity Read

Molecular landscape and multi-omic measurements of heterogeneity in fetal adenocarcinoma of the lungSemantic proximity Read

Multi-omics analysis of molecular landscape and heterogeneity in fetal adenocarcinoma of the lungSemantic proximity Read